Impact of Baseline Quantitative OCT Features on Response to Risuteganib for the Treatment of Dry Age-Related Macular Degeneration
- Resource Type
- Article
- Authors
- Abraham, Joseph R.; Jaffe, Glenn J.; Kaiser, Peter K.; Chiu, Stephanie J.; Loo, Jessica; Farsiu, Sina; Bouckaert, Laurens; Karageozian, Vicken; Sarayba, Melvin; Srivastava, Sunil K.; Ehlers, Justis P.
- Source
- Ophthalmology Retina; November 2022, Vol. 6 Issue: 11 p1019-1027, 9p
- Subject
- Language
- ISSN
- 24687219; 24686530
The purpose of the study was to perform a post hoc analysis to explore the effect of baseline anatomic characteristics identified on OCT on best-corrected visual acuity (BCVA) responses to risuteganib from the completed phase II study in subjects with dry age-related macular degeneration (AMD).